Table 7.
Group |
LDL oxidation
+
|
||||
---|---|---|---|---|---|
Conjugated diene formation * | MDA content # | ||||
Basal | Maximal | Lag Phase ** | Basal | Maximal ¥ | |
N-C | 178.49 | 945.86 (+430%) |
88 | 5.43±0.212 | 15.26 |
S-C | 264.36 (+48.3%)† |
1348.56 (+42.6%)€ |
68 (-22.7%)¶ |
8.64±0.364a (+53.2%)† |
23.65 (+54.9%)€ |
FVT-1 | 234.72 (-11.4%)†† |
1264.35 (-6.2%)α |
75 (+10.3%)§ |
7.43±0.202 b (-14.0%)†† |
20.26 (-14.3%) # |
FVT-2 | 192.41 (-27.3%)†† |
1048.95 (-22.2%) α |
85 (+25.0%)§ |
6.24±0.244 a (-27.8%)†† |
18.45 (-21.9%) # |
C-T | 187.32 (-29.2%)†† |
989.35 (-26.6%) α |
87 (+27.9%)§ |
5.87±0.231 a (-32.1%)†† |
16.6 (-29.8%) # |
A-T | 244.54 (-7.5%)†† |
1294.28 (-4.0%) α |
73 (+7.4%)§ |
7.56±0.292 c (-12.5%)†† |
20.43 (-13.6%) # |
N-C: normal control, S-C: smoke-exposed control, FVT-1: fed 50 mg FVBM extract/rat/day; FVT-2: fed 100 mg FVBM extract/rat/day, C-T, fed 1 mg F18 bioactive compound/rat/day and A-T: given 1 mg atorvastatin/rat/day for 4 weeks.
MDA: Malondialdehyde.
Significantly different from N-C at
The CD values are expressed as nmole MDA equivalents/mg protein. Basal conjugated diene represent the in-vivo status of oxidized LDL.
The lag phase is defined as the interval between the intercept of the tangent of the slope of the curve with the time expressed in minutes.
The maximum in-vitro oxidation of LDL was achieved after 12 h of incubation with CuSo4 in each group,
Percent increase with respect to basal value in N-C,
Percent decrease with respect to basal value in S-C,
Percent decrease with respect to lag phase value in N-C,
Percent increase with respect to lag phase value in S-C,
Percent increase with respect to maximal value in N-C,
Percent decrease with respect to maximal value in S-C, Significantly different from N-C at
P < 0.001.
Values are obtained from LDL subpopulation, isolated from plasma of 5 rats in each group.
p < 0.01, significantly different from S-C at
p < 0.05.